Novavax Inc. Stock Rises Wednesday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. (NVAX) rose 2.93% to $11.23 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 2.00% to 11,816.32 and the Dow Jones Industrial Average rising 0.02% to 34,092.96. This was the stock's second consecutive day of gains. Novavax Inc. closed $90.16 below its 52-week high ($101.39), which the company reached on February 7th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.92% to $164.92, Pfizer Inc. (PFE) fell 0.43% to $43.97, and Merck & Co. Inc. (MRK) fell 0.40% to $106.98. Trading volume (10.6 M) eclipsed its 50-day average volume of 7.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 1, 2023.
(END) Dow Jones Newswires
February 01, 2023 17:14 ET (22:14 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.